IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Dr. Reddy’s and GSK Form Alliance in Emerging Markets

6:11 AM MDT | June 29, 2009 | DEEPTI RAMESH

Dr. Reddy’s Laboratories (Hyderabad, India) says it has entered into an agreement with GlaxoSmithKline (GSK; London) to develop and market select products in several emerging markets, excluding India. Financial terms of the deal were not disclosed. Hussain: Demand for drugs rising in some regions. Dr. Reddy’s says this is the first such alliance between the two companies. The deal calls for GSK to gain exclusive access to Dr. Reddy’s portfolio and future pipeline of more than 100 branded pharmaceuticals in fast-growing therapeutic segments such...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa